Article info
PDFJustice
Paper
Chronic disease as risk multiplier for disadvantage
- Correspondence to Francisca Stutzin Donoso, Centre for Multidisciplinary and Intercultural Inquiry, Health Humanities, University College London, London, UK; francisca.stutzin.15{at}ucl.ac.uk
Citation
Chronic disease as risk multiplier for disadvantage
Publication history
- Received April 8, 2017
- Revised December 29, 2017
- Accepted February 6, 2018
- First published March 6, 2018.
Online issue publication
May 24, 2018
Article Versions
- Previous version (24 May 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Effects of integrated models of care for diabetes and hypertension in low-income and middle-income countries: a systematic review and meta-analysis
- Strengthening the global paediatric workforce: the need for a global strategy to ensure better health outcomes for children
- The hidden costs of universal health coverage: solutions from the fight against catastrophic healthcare expenditure in Thailand
- Integration of non-communicable disease and HIV/AIDS management: a review of healthcare policies and plans in East Africa
- The impact of user charges on health outcomes in low-income and middle-income countries: a systematic review
- Trends and outcomes in primary health care expenditures in low-income and middle-income countries, 2000–2017
- Achieving high-quality universal health coverage: a perspective from the National Health Service in England
- Setting priorities to address cardiovascular diseases through universal health coverage in low- and middle-income countries
- Refocusing the World Health Organization’s Model List of Essential Medicines on the needs of low and middle income countries
- Monitoring and evaluating the implementation of essential packages of health services